When was Alkymos founded?

Alkymos was founded in 2006 and raised its 1st funding round within a year of its incorporation.

Where is Alkymos located?

Alkymos is headquartered in Lexington, United States.

Is Alkymos a funded company?

Alkymos is a funded company, having raised a total of $644K across 8 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Dec 01, 2006.

When was the latest funding round of Alkymos?

Alkymos' latest funding was a $***** Seed round on Mar 10, 2015, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does Alkymos rank among its competitors?

Alkymos ranks 10th amongst 20 active competitors, of which 3 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Tanda Biotech, which secured $75K in Feb, 2026.

Who are the top competitors of Alkymos?

Alkymos' top competitors include Cytosorbents, TeraPore and SANI Membranes. Among them, Tanda Biotech secured the most recent funding round in February, 2026.

Alkymos - 2026 Company Profile, Team, Funding & Competitors

Company Details

Alkymos have developed a single-use, self-contained, point-of-care flow-through filter containing an immobilized chelator to complex with and remove aluminum from calcium gluconate injections used in the preparation of parenteral nutrition solutions. The company has published data to show that its ACE filter can reduce Al delivered in parenteral nutrition solutions by approximately 72%, bringing the delivered Al to levels below that results in Al accumulation associated CNS and bone toxicities in a majority of infants.

Key Metrics

Founded Year

2006

Location

Lexington, United States

Stage

Deadpooled

Total Funding

$644K in 8 rounds

Latest Funding Round

Seed, Mar 10, 2015, $*****

Investors

Enterprise Angels Community Fund I & 2 more

Ranked

10^th among 20 active competitors

Similar Companies

Cytosorbents & 20 more

View Alkymos' full profile

Alkymos has raised a total funding of $644K over 8 rounds. Its first funding round was on Dec 01, 2006. Alkymos has 3 institutional investors.

Here is the list of recent funding rounds of Alkymos:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 10, 2015	4571146	Seed	7945974	6081941	3167524	9554904
Dec 2014	6916694	Seed	1602025	8594187	8494281	1416982
Nov 21, 2013	7114123	Seed	9682105	9188218	4990662	5925609

Access funding benchmarks and valuations. Sign up today!

View details of Alkymos's funding rounds and investors

The founders of Alkymos is Robert Yokel.

Here are the details of Alkymos' key team members:

Robert Yokel: Founder & President of Alkymos.

View details of Alkymos's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alkymos include Cytosorbents, TeraPore and SANI Membranes. Here is the list of Top 10 competitors of Alkymos, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cytosorbents 1997, Monmouth Junction (United States), Public	Developer of hemoperfusion technology for removing toxins from the blood	$22M	Western Alliance Bank, NJTC Venture Fund & 5 others	66/100
2nd	TeraPore 2013, San Francisco (United States), Series B	Developer of bioseparation solutions for therapeutics and novel biologics	$19.5M	Anzu Partners, RA Capital Management & 8 others	46/100
3rd	SANI Membranes 2013, Vaerlose (Denmark), Unfunded	Developer of advanced filtration systems for bimolecular separation	-	-	31/100
4th	Szmeizhao 2002, Shenzhen (China), Funding Raised	Provider of integrated solutions for digital hospital environment and energy management	-	Dami Ventures, China Investment LuckyStone Management ... Read more	31/100
5th	Hermes Bioscience 2024, San Francisco (United States), Seed	Developer of benchtop extracellular vesicle isolation technology to purify exosomes	-	Genoa Ventures, Vertical Venture Partners ... & 1 others	29/100
6th	Filtravate 2020, Las Cruces (United States), Seed	Provider of ultrafiltration membranes for bioprocessing and pharmaceutical industries	$300K	VIC Technology Venture Development, National Science Foundation ... Read more	29/100
7th	Membrana 1998, Charlotte (United States), Acquired	Manufacturer of filtration membranes for life sciences industries	-	-	28/100
8th	Bioimmunate 2014, Jerusalem (Israel), Funding Raised	Developer of blood filtration devices for autoimmune diseases	-	K3, Sanfrance Capital	27/100
9th	Tanda Biotech 2023, Buffalo Grove (United States), Funding Raised	Developer of filtration technologies for biomanufacturing scalability and cost efficiency	-	Illinois Science Technology, National Science Foundation ... Read more	26/100
10th	Alkymos 2006, Lexington (United States), Deadpooled	Chelators and chelator-based filtration devices	$644K	Enterprise Angels Community Fund I, SBIR & 1 others	25/100